These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12161053)

  • 1. The effects of losartan and fosinopril in hypertensive type 2 diabetic patients.
    Kavgaci H; Sahin A; Onder Ersoz H; Erem C; Ozdemir F
    Diabetes Res Clin Pract; 2002 Oct; 58(1):19-25. PubMed ID: 12161053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients.
    Fogari R; Preti P; Zoppi A; Rinaldi A; Corradi L; Pasotti C; Poletti L; Marasi G; Derosa G; Mugellini A; Voglini C; Lazzari P
    Am J Hypertens; 2002 Dec; 15(12):1042-9. PubMed ID: 12460699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
    Tatti P; Pahor M; Byington RP; Di Mauro P; Guarisco R; Strollo G; Strollo F
    Diabetes Care; 1998 Apr; 21(4):597-603. PubMed ID: 9571349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria.
    Esmatjes E; Flores L; Iñigo P; Lario S; Ruilope LM; Campistol JM
    Nephrol Dial Transplant; 2001; 16 Suppl 1():90-3. PubMed ID: 11369831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy.
    Krum H; Skiba M; Gilbert RE
    Diabet Med; 2003 Sep; 20(9):708-12. PubMed ID: 12925048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics.
    Lozano JV; Llisterri JL; Aznar J; Redon J;
    Nephrol Dial Transplant; 2001; 16 Suppl 1():85-9. PubMed ID: 11369830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
    Tong PC; Ko GT; Chan WB; Ma RC; So WY; Lo MK; Lee KF; Ozaki R; Chow CC; Cockram CS; Chan JC
    Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.
    Andersen S; Jacobsen P; Tarnow L; Rossing P; Juhl TR; Parving HH
    Nephrol Dial Transplant; 2003 Feb; 18(2):293-7. PubMed ID: 12543883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy.
    Yasuda G; Ando D; Hirawa N; Umemura S; Tochikubo O
    Diabetes Care; 2005 Aug; 28(8):1862-8. PubMed ID: 16043724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
    Yu G; Liang X; Xie X; Yang T; Sun M; Zhao S
    Chin Med J (Engl); 2002 Sep; 115(9):1287-91. PubMed ID: 12411096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats.
    Yu G; Liang X; Xie X; Su M; Zhao S
    Int J Cardiol; 2001 Dec; 81(2-3):123-9; discussion 129-30. PubMed ID: 11744126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.
    Zandbergen AA; Baggen MG; Lamberts SW; Bootsma AH; de Zeeuw D; Ouwendijk RJ
    Ann Intern Med; 2003 Jul; 139(2):90-6. PubMed ID: 12859158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
    Fogari R; Zoppi A; Preti P; Fogari E; Malamani G; Mugellini A
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):921-6. PubMed ID: 11587159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients.
    Fogari R; Zoppi A; Corradi L; Lazzari P; Mugellini A; Lusardi P
    Br J Clin Pharmacol; 1998 Nov; 46(5):467-71. PubMed ID: 9833600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal dose of losartan for renoprotection in diabetic nephropathy.
    Andersen S; Rossing P; Juhl TR; Deinum J; Parving HH
    Nephrol Dial Transplant; 2002 Aug; 17(8):1413-8. PubMed ID: 12147788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of Fixed Dose Combination of Ramipril/Amlodipine in Hypertensive Diabetic Patients: A Subgroup Analysis of RAMONA Trial.
    Simonyi G
    Chin Med J (Engl); 2016 May; 129(10):1224-8. PubMed ID: 27174332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction.
    Houlihan CA; Akdeniz A; Tsalamandris C; Cooper ME; Jerums G; Gilbert RE
    Diabetes Care; 2002 Jun; 25(6):1072-7. PubMed ID: 12032117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.